Eric Mayer has been the President and Chief Executive Officer of New Day Diagnostics since 2023, following the merger of New Day Diagnostics and EDP Biotech, where he had served as Chief Executive Officer since 2015. Eric previously served as Vice President of Business Development at EDP Biotech, overseeing various aspects of product development, intellectual property, and forming alliances with manufacturing
partners.

Earlier in his career, Eric Mayer directed business development at BioPet Vet Lab, resulting in the market launch, distribution, and subsequent revenue growth of BioPet’s primary genetic product. His experience includes nearly a decade of start-up biotech involvement with diagnostic firms such as AAD, Inc., and research companies such as Metabolon, Inc. and Cirrus Pharmaceuticals.

Eric received his B.S. in Biochemistry from UNC Chapel Hill, and his M.S. in Microbial Biotechnology and M.B.A. from North Carolina State University.